Personalized treatment strategies have advanced the management of lung cancer brain metastases, improving patient outcomes with targeted therapies and immunotherapies.
Stereotactic radiosurgery and whole-brain radiation therapy are evolving in their roles due to novel systemic therapies.
Multidisciplinary approaches are crucial for optimizing treatment plans, considering genetic mutations and patient performance status.
Continuous research and clinical trials are essential for further progress in managing lung cancer brain metastases.
SHOW MORE
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.